Milestone Pharmaceuticals (MIST) Free Cash Flow Growth (3y) (2021 - 2026)
Milestone Pharmaceuticals (MIST) Free Cash Flow Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,899.61 Bn | 65,899.33 Bn | - | -5.05% |
| 2 | Nanobiotix | 1,933.82 Bn | 1,933.76 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | - |
| 4 | BeOne Medicines | 471.67 Bn | 466.88 Bn | 1.35 Bn | 31.07% |
| 5 | Vertex Pharmaceuticals | 122.32 Bn | 115.07 Bn | 2.59 Bn | 14.71% |
| 6 | Regeneron Pharmaceuticals | 70.04 Bn | 61.29 Bn | 3.31 Bn | -10.65% |
| 7 | Belite Bio | 62.06 Bn | 62.06 Bn | - | - |
| 8 | Argenx Se | 55.93 Bn | 50.74 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.55 Bn | 34.54 Bn | 959.66 Mn | 31.42% |
| 10 | Milestone Pharmaceuticals | 152.00 Mn | -32.21 Mn | - | -4.92% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.92% |
| Dec 31, 2025 | -0.22% |
| Sep 30, 2025 | 5.83% |
| Jun 30, 2025 | 3.70% |
| Mar 31, 2025 | -0.02% |
| Dec 31, 2024 | 17.84% |
| Sep 30, 2024 | 9.24% |
| Jun 30, 2024 | -99.70% |
| Mar 31, 2024 | 10.52% |
| Dec 31, 2023 | -3.92% |
| Sep 30, 2023 | -18.42% |
| Jun 30, 2023 | 13.84% |
| Mar 31, 2023 | 8.31% |
| Dec 31, 2022 | 8.08% |
| Sep 30, 2022 | -10.76% |
| Jun 30, 2022 | -6.94% |
| Mar 31, 2022 | 1.81% |
| Dec 31, 2021 | -19.18% |
| Sep 30, 2021 | -18.87% |
| Jun 30, 2021 | 31.94% |